Himed and Adva Cera Partner to Create a Seamless Prototype-to-Production Path for 3D-Printed Bioceramic Medical Devices
Developing a successful bioceramic implant requires more than an innovative design—it requires a clear path to manufacturing. Through a new partnership with Adva Cera, Himed is expanding the capabilities of its Bioceramics Center of Excellence™ to help medical device companies move optimized 3D-printed calcium phosphate implant designs from R&D into qualified, production-scale manufacturing with greater efficiency and continuity.
Himed and I&H Global Mark 15 Years of Strategic Sales Partnership in South Korea
Himed celebrates 15 years of partnership with I&H Global, its exclusive sales representative in South Korea, where the collaboration has helped expand the use of bioceramic materials among leading dental and orthopedic implant manufacturers. Together, the two companies continue to advance biomaterials innovation in one of Asia’s fastest-growing medical markets.
Himed and Lithoz Announce Launch of New Bioceramics Center of Excellence™
Himed and Lithoz are pleased to announce the launch of a new Bioceramics Center of Excellence™ (BCoE) at Himed's New York headquarters. The BCoE will offer a holistic approach to bioceramics R&D for medical device manufacturers, integrating various analytical services to support rapid prototyping and device customization.
Global Biomaterials Manufacturer Himed Announces Leadership Transition in 2024
Craig Rosenblum has been appointed as the new President of Himed. He succeeds Ed Garofalo, who will be transitioning into the advisory position of President Emeritus. Rosenblum’s guidance has helped propel Himed to achieve remarkable milestones and solidified its position as an industry leader in biomaterials for medical devices, leading to his promotion. Having joined the company in 2015, he has seamlessly transitioned through three distinct roles…
Himed and Mercury Bio Team Up to Develop Unique Osteogenic Materials for Orthopedic Applications
Himed has entered a new realm of research this month with the formalizing of a research and development agreement with Santa Fe, NM-based Mercury Bio.
As a global supplier of calcium phosphate materials and implant surface treatments that support bone repair, Himed wishes to explore the frontiers of organic CaP integrations at the molecular level, and was seeking a partner with promising IP for small particle delivery. We were fortunate to find that partner in Mercury Bio, which has developed a novel advanced drug delivery system that could prove effective at also loading and targeting CaP compounds.